ABSTRACT
Objetivo: o propósito deste estudo foi revisar os possíveis mecanismos de ação dos microRNAs na doença periodontal. Material e Métodos: o estudo foi baseado em artigos científicos encontrados na base de dados PubMed. Resultados: a recente descoberta de microRNAs (miRNAs) revolucionou a maneira como a regulação gênica é analisada. Estudos demonstram que os miRNAs podem atuar na resposta inata, em vários estágios, entre eles na sinalização de receptores Toll-like. Os miRNAs também estão relacionados à regulação de elementos centrais da resposta imune adaptativa, como apresentação de antígenos. No entanto, muito ainda precisa ser estudado para identificar a atividade de miRNAs na regulação gênica. A doença periodontal é uma doença bucal causada por patógenos bacterianos, com resposta inflamatória e imune agressiva, que afeta os tecidos ao redor dos dentes, podendo levar à sua perda. Conclusão: concluiu-se que os recentes achados do papel dos microRNAs na resposta inflamatória, incluindo tanto a imunidade inata como a adaptativa, ocorrem na doença periodontal
Objective: the purpose of this study was to review the role of possible mechanisms of action of microRNAs in periodontal disease. Material and Methods: the study was based on PubMed scientific papers. Results: the recent discovery of microRNAs (miRNAs) has revolutionized the way that gene regulation is analyzed. Studies demonstrate that they can act on the innate response, in several stages, among them the signaling of Toll-like receptors. The miRNAs are also related to the regulation of central elements of the adaptive immune response, such as antigen presentation. However, much still needs to be studied to identify miRNAs activity in gene regulation. Periodontal disease is an oral disease caused by bacterial pathogens, with an aggressive immune and inflammatory response, which affects the tissues around the teeth, which may lead to their loss. Conclusion: it was concluded that the recent findings of the role of microRNAs in the inflammatory response, including both innate and adaptative immunity, that occurs in periodontal disease
Subject(s)
Periodontal Diseases , Periodontitis , MicroRNAs , InflammationABSTRACT
Abstract Porphyromonas gingivalis is one of the most important Gram-negative anaerobe bacteria involved in the pathogenesis of periodontitis. P. gingivalis has an arsenal of specialized virulence factors that contribute to its pathogenicity. Among them, fimbriae play a role in the initial attachment and organization of biofilms. Different genotypes of fimA have been related to length of fimbriae and pathogenicity of the bacterium. Objectives The aim of this study was to identify 5 types of fimA genotype strains in smokers and nonsmokers with periodontitis, before and after periodontal therapy. Material and Methods Thirty-one patients with periodontitis harboring P. gingivalis were selected: 16 nonsmokers (NS) and 15 smokers (SM). Clinical and microbiological parameters were evaluated at baseline and 3 months after periodontal treatment, namely: plaque index, bleeding on probe, probing depth, gingival recession and clinical attachment level. The frequency of P. gingivalis and fimA genotype strains were determined by polymerase chain reaction. Results Type I fimA was detected in the majority of SM and NS at baseline, and the frequency did not diminish after 3 months of treatment. The frequency of type II genotype was higher in SM than NS at baseline. After 3 months, statistical reduction was observed only for types II and V fimA genotypes in SM. The highest association was found between types I and II at baseline for NS (37.5%) and SM (53.3%). Conclusion The most prevalent P. gingivalis fimA genotypes detected in periodontal and smoker patients were genotypes I and II. However, the presence of fimA genotype II was higher in SM. Periodontal treatment was effective in controlling periodontal disease and reducing type II and V P. gingivalis fimA.